You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

naquotinib

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations Trial in United States (naquotinib, midazolam)

Completed
  • Non-Small-Cell Lung Cancer (NSCLC)
  • Epidermal Growth Factor Receptor Mutations
  • Washington, District of Columbia
  • +11 more
Jan 15, 2020

NSCLC (NSCLC), Epidermal Growth Factor Receptor (EGFR) Mutations Trial in Beverly Hills, The Woodlands, Fairfax (naquotinib)

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • Epidermal Growth Factor Receptor (EGFR) Mutations
  • naquotinib
  • Beverly Hills, California
  • +2 more
Aug 30, 2018

Epidermal Growth Factor Receptor (EGFR) Mutations, Solid Tumors Trial (radio-labeled naquotinib, naquotinib)

Withdrawn
  • Epidermal Growth Factor Receptor (EGFR) Mutations
  • Solid Tumors
  • radio-labeled naquotinib
  • naquotinib
  • (no location specified)
Jul 26, 2017